RSLS
ReShape Lifesciences Inc.
-48.86%
$5.91 - $3.02
Feb 8th 2023 - Mar 22nd 2023
Feb, 18, 2023
but strong catalysts and progress with little to n... See more
Jan, 27, 2023
300-500% Gainers post r/s.
BXRX
Baudax Bio Inc
-52.79%
$3.41 - $1.61
Feb 7th 2023 - Mar 21st 2023
Mar, 12, 2023
Company doubled in size and reduced cash burn with... See more
Mar, 10, 2023
No risk of dilution and short interest has spiked, 500% increase.
HTGM
HTG Molecular Diagnostics Inc
-37.26%
$4.67 - $2.93
Feb 7th 2023 - Mar 21st 2023
Mar, 15, 2023
The have enough cash to last them for the next 1.5... See more
Jan, 10, 2023
So no dilution fears.
Feb, 18, 2023
but strong catalysts and progress with little to no dilution increase the odds of a much higher price of the stock.
Jan, 27, 2023
300-500% Gainers post r/s.
Jan, 4, 2023
Another one with FDA news like r/s name, with good technical , reminds me of $RSLS $MSGM yesterday , which ran nice 7+ is the signal
Jan, 3, 2023
$RSLS Dilution I guarantee it.
Dec, 28, 2022
Post R/S gonna see a big spike.
Nov, 1, 2022
After the dilution and R/S shorts are going to make MASSIVE profits.
Mar, 12, 2023
Company doubled in size and reduced cash burn with no risk of dilution.
Mar, 10, 2023
No risk of dilution and short interest has spiked, 500% increase.
Jan, 5, 2023
Both went up over 100% after the r/s and before the capital raise.
Dec, 10, 2022
No r/s risk and atm this year $xela $muln $BBIG $SMMT
Dec, 2, 2022
$BXRX two r/s in a year..π€¦ββοΈπ€¦ββοΈ
Dec, 1, 2022
$BXRX performed RS just recently, dilution at its finest
Mar, 15, 2023
The have enough cash to last them for the next 1.5 years, no exposure to dilution and have 6 drugs in the pipeline.
Jan, 10, 2023
So no dilution fears.
Jan, 5, 2023
Both went up over 100% after the r/s and before the capital raise.
Dec, 27, 2022
COSM is primed in the buy zone with a nice short % no dilution risk.
Dec, 20, 2022
Would have loved for HTGM to R/S first, makes for a more interesting pump.